OliX PharmaceuticalsInc (226950) — Working Capital to Net Assets Ratio
OliX PharmaceuticalsInc (226950) has a Working Capital to Net Assets ratio of 84.6% as of June 2026. Working capital of ₩200.87 Billion (current assets of ₩219.58 Billion minus current liabilities of ₩18.71 Billion) is measured against net assets of ₩237.42 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
OliX PharmaceuticalsInc Working Capital to Net Assets (2016–2025)
This chart shows how OliX PharmaceuticalsInc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 84.6%, reflecting working capital of ₩200.87 Billion against net assets of ₩237.42 Billion KRW. Explore 226950 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Working Capital to Net Assets for OliX PharmaceuticalsInc (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for OliX PharmaceuticalsInc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see OliX PharmaceuticalsInc balance sheet assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 79.6% | ₩119.53 Billion | ₩150.08 Billion | ₩140.85 Billion | ₩21.33 Billion | ▲ +161.0 pp |
| 2024 | -81.4% | ₩-14.53 Billion | ₩17.85 Billion | ₩15.53 Billion | ₩30.06 Billion | ▼ -132.2 pp |
| 2023 | 50.8% | ₩25.58 Billion | ₩50.34 Billion | ₩32.14 Billion | ₩6.56 Billion | ▲ +12.1 pp |
| 2022 | 38.7% | ₩25.50 Billion | ₩65.91 Billion | ₩65.05 Billion | ₩39.54 Billion | ▼ -25.4 pp |
| 2021 | 64.1% | ₩11.87 Billion | ₩18.52 Billion | ₩52.24 Billion | ₩40.37 Billion | ▼ -78.4 pp |
| 2020 | 142.6% | ₩64.56 Billion | ₩45.29 Billion | ₩69.05 Billion | ₩4.49 Billion | ▲ +59.6 pp |
| 2019 | 83.0% | ₩34.69 Billion | ₩41.80 Billion | ₩37.44 Billion | ₩2.75 Billion | ▼ -5.1 pp |
| 2018 | 88.1% | ₩48.38 Billion | ₩54.94 Billion | ₩48.70 Billion | ₩314.09 Million | ▲ +7.0 pp |
| 2017 | 81.1% | ₩15.14 Billion | ₩18.68 Billion | ₩16.17 Billion | ₩1.03 Billion | ▲ +7.4 pp |
| 2016 | 73.7% | ₩9.25 Billion | ₩12.56 Billion | ₩10.08 Billion | ₩831.74 Million | — |